Oseltamivir analogs with potent anti-influenza virus activity. Issue 8 (August 2020)
- Record Type:
- Journal Article
- Title:
- Oseltamivir analogs with potent anti-influenza virus activity. Issue 8 (August 2020)
- Main Title:
- Oseltamivir analogs with potent anti-influenza virus activity
- Authors:
- Kumar, Sumit
Goicoechea, Steven
Kumar, Sonu
Pearce, Catherine M.
Durvasula, Ravi
Kempaiah, Prakasha
Rathi, Brijesh
Poonam, - Abstract:
- Highlights: Despite of vaccines, therapeutics are critically important to keep check on evolving virulence from mutations. Oseltamivir remains a single effective oral drug against influenza infections. High potency of guanidino-oseltamivir carboxylate is compromised due to poor oral bioavailability. Viral neuraminidase represents a key target for the discovery of new OS analogs due to its essentiality. Abstract : Influenza A and B viruses cause seasonal worldwide influenza epidemics each winter, and are a major public health concern and cause of morbidity and mortality. A substantial reduction in influenza-related deaths can be attributed to both vaccination and administration of oseltamivir (OS), which is approved for oral administration and inhibits viral neuraminidase (NA), a transmembrane protein. OS carboxylate (OSC), the active form of OS, is formed by the action of endogenous esterase, which targets NA and is shown to significantly reduce influenza-related deaths. However, the development of resistance in various viral variants, including H3N2 and H5N1, has raised concern about the effectiveness of OS. This comprehensive review covers a range of OS analogs shown to be effective against influenza virus, comparing different types of substituent group that contribute to the activity and bioavailability of these compounds. Teaser: Oseltamivir, a single effective oral drug available for the treatment of influenza infections, makes the discovery of its analogs valuable andHighlights: Despite of vaccines, therapeutics are critically important to keep check on evolving virulence from mutations. Oseltamivir remains a single effective oral drug against influenza infections. High potency of guanidino-oseltamivir carboxylate is compromised due to poor oral bioavailability. Viral neuraminidase represents a key target for the discovery of new OS analogs due to its essentiality. Abstract : Influenza A and B viruses cause seasonal worldwide influenza epidemics each winter, and are a major public health concern and cause of morbidity and mortality. A substantial reduction in influenza-related deaths can be attributed to both vaccination and administration of oseltamivir (OS), which is approved for oral administration and inhibits viral neuraminidase (NA), a transmembrane protein. OS carboxylate (OSC), the active form of OS, is formed by the action of endogenous esterase, which targets NA and is shown to significantly reduce influenza-related deaths. However, the development of resistance in various viral variants, including H3N2 and H5N1, has raised concern about the effectiveness of OS. This comprehensive review covers a range of OS analogs shown to be effective against influenza virus, comparing different types of substituent group that contribute to the activity and bioavailability of these compounds. Teaser: Oseltamivir, a single effective oral drug available for the treatment of influenza infections, makes the discovery of its analogs valuable and interesting. … (more)
- Is Part Of:
- Drug discovery today. Volume 25:Issue 8(2020)
- Journal:
- Drug discovery today
- Issue:
- Volume 25:Issue 8(2020)
- Issue Display:
- Volume 25, Issue 8 (2020)
- Year:
- 2020
- Volume:
- 25
- Issue:
- 8
- Issue Sort Value:
- 2020-0025-0008-0000
- Page Start:
- 1389
- Page End:
- 1402
- Publication Date:
- 2020-08
- Subjects:
- Drugs -- Design -- Periodicals
Drugs -- Research -- Periodicals
615.1 - Journal URLs:
- http://www.sciencedirect.com/science/journal/13596446 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.drudis.2020.06.004 ↗
- Languages:
- English
- ISSNs:
- 1359-6446
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.120500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23539.xml